A Vaccine for Type 1 Diabetes is Headed for Human Trials in 2019
Articles Blog

A Vaccine for Type 1 Diabetes is Headed for Human Trials in 2019

October 16, 2019

after 25 years of dedicated research a
potential vaccine for type 1 diabetes developed in Finland is headed for human
clinical trials by the year 2050 it’s anticipated that in the US alone 5
million people will be diagnosed with type 1 diabetes this autoimmune disease
which affects children and adults is currently unable to be prevented or
cured in order to manage t1d people with the condition must constantly monitor
their blood glucose levels and manage those levels through insulin injection
activity and diet in order to avoid life-threatening complications it has
been suggested for quite some time now that t1d could be related to viral
infection which has lead some to propose the possibility of creating a vaccine
for the disease in Finland researchers have been exploring this connection in
potential vaccine for approximately 25 years after such a laborious scientific
journey they believe they’ve found the viral group that can trigger t1d the
hard work seems to have paid off as the team has created a prototype vaccine
which will move into human clinical trials by 2018 the future of type 1
diabetes while it’s unlikely that the vaccine would become an immediate
cure-all t1d if the trials proved successful it will
dramatically shift the future of the disease up until this point
patients with t1d have been required to vigilantly self-manage
complications of the disease which can result when it goes undiagnosed or is
ineffectively managed can range from heart attack to stroke amputation kidney
failure and even blindness the threat of these complications constantly hangs
over the heads of those with t1d unfortunately as the team notes this
vaccine would not be a cure for t1d but if it proves successful in
preventing the onset of the condition it could change the lives of millions of
people around the world

Only registered users can comment.

  1. I provided help to two persons who`re coping with Type two diabetes by showing them “Vαnοjο Fivu”. One of these was able to lessen his HA1c to 5.9 and triumphed in treating his diabetes. The other gentleman has drastically improved, his standard fasting blood sugar is 110mg/dL and he`s out of complication from heart trauma, from sacrificing his arms, legs, eye impairment or neuropathy..

Leave a Reply

Your email address will not be published. Required fields are marked *